Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07249762 · ClinicalTrials.gov registry record

Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1

A clinical trial, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Not yet
Registry status
40
Enrollment target

NCT07249762: Clinical Trial study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

NCT07249762 is a clinical trial that has not yet begun recruiting, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07249762 has not yet begun recruiting, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

NOT YET RECRUITING
Registry status
40 participants
Enrollment target

Study Summary

This study is following adult patients with serious burn injuries to better understand how their bodies respond to treatment and recovery. Researchers will collect small amounts of blood and tissue samples, along with information already recorded in the medical record, such as vital signs, lab results, and details of surgeries or complications. The goal is to identify patterns that may help predict who is at higher risk for infections or other problems after a burn injury. This information could lead to new tools, including computer-based models, to improve burn care and outcomes in the future. Participation involves providing samples and allowing researchers to review medical records during the hospital stay and up to one year after discharge.

Primary Outcome

Clinical data will be collected from medical records to capture whether patients develop sepsis, organ dysfunction, or other serious complications following burn injury.

Interventions

  • OTHER Observational Cohort (No Intervention)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-05-15
Est. Completion 2027-12-15

What is known before NCT07249762 opens enrollment

NCT07249762 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Observational Cohort (No Intervention) is the first listed.

NCT07249762 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07249762 about?

NCT07249762 is a clinical study titled "Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1". This study is following adult patients with serious burn injuries to better understand how their bodies respond to treatment and recovery. Researchers will collect small amounts of blood and tissue samples, along with information already recorded in the medical record, such as vital signs, lab resul...

What is the current status of trial NCT07249762?

This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2026-05-15. Estimated completion is 2027-12-15.

What interventions are being tested in trial NCT07249762?

The interventions under investigation include: Observational Cohort (No Intervention) (OTHER).

Who is sponsoring clinical trial NCT07249762?

This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07249762, the US trial registry maintained by the National Library of Medicine. NCT07249762 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.